December 22, 2016 / 12:24 PM / 8 months ago

BRIEF-Novelion Therapeutics says unit seeking EMA approval for metreleptin drug

Dec 22 (Reuters) - Novelion Therapeutics Inc

* Novelion Therapeutics - unit submitted MAA to EMA seeking approval for metreleptin as replacement therapy to treat complications of leptin deficiency

* Novelion Therapeutics Inc - company, through its subsidiary, will seek to market metreleptin in EU under tradename myalepta Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below